Pursuant to the provisions of Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Johnson Pharmacare has informed that the meeting of the Board of Directors of the Company was held today i.e., 13th February, 2026, which commenced at 12:15 pm and concluded at 12:45 pm. The Board of Director have considered and approved the appointment of VRSK & Associates (FRN:011199N) as Statutory Auditor of the Company to fill the casual vacancy with effect from 13.02.2026. Consent to act as statutory auditor is annexed. The Board has appointed Parul Agrawal (DIN: 11268580) as an Additional Non-Executive & Independent Director of the Company with effect from 13th February, 2026 a brief profile pursuant to SEBI Circular dated CIR/CFD/CMD/4/2015 dated September 09, 2015 is enclosed as (Attached as Annexure). Further Parul Agrawal (DIN: 11268580) is not related to the Directors or Key Managerial Personnel of the Company and is also not debarred from holding the office of Director by virtue of any SEBI order or any other authority.

The above information is a part of company’s filings submitted to BSE.